Rapid Dose Therapeutics obtains license to sell cannabis from Health Canada

0

RDT-branded QuickSips ™ and QuickStrip ™ will be available in stores coast to coast

BURLINGTON (Ontario), October 01, 2021– (BUSINESS WIRE) – Rapid Dose Therapeutics Corp. (“RDT“or the”Society“) (CSE: DOSE), a Canadian biotech company that is revolutionizing drug delivery through innovation, today announced that it has successfully received its license to sell cannabis from Health Canada following an application and approval process. rigorous inspection. This is in addition to the microprocessing license received on November 15, 2019, which allowed RDT to offer white label products to several Canadian producers.

“Today marks another achievement at RDT with the receipt of our cannabis sales license from Health Canada and we are very pleased to be able to offer Canadian patients and cannabis consumers our innovative branded products,” said Mark Upsdell , CEO of Rapid Dose Therapeutics. “The new dosage and delivery of our QuickStrip and QuickSip products make them ideal for use by a wide range of consumers and we see a tremendous opportunity to leverage our technology with a number of key targets, both on recreational and medical markets, including long-term markets. long-term care and assisted living. “

The first commercial RDT cannabis product, a 10 mg THC-lined QuickSips, will soon be released in cannabis stores across Ontario, followed shortly thereafter by the RDT QuickStrip 10 mg THC Sublingual Oral Dissolution Strip. RDT has entered into a Master Distribution Agreement with CannMart Inc. (formerly Namaste Technologies Inc.) now Lifeist (TSXV: N), (FRANKFURT: M5BQ), (OTCMKTS: NXTTF) for the exclusive sale and distribution of cannabis products RDT brand in retail stores across Canada.

About Rapid Dose Therapeutics Corp.

Rapid Dose Therapeutics is a Canadian biotechnology company that is revolutionizing drug delivery through innovation. The company’s flagship product, QuickStrip ™, is an orally soluble thin film, which can be infused with an endless list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient.
www.rapid-dose.com

CAUTION REGARDING FORWARD-LOOKING STATEMENTS:
Certain information contained in this press release may contain forward-looking information within the meaning of applicable securities laws. All statements contained in this press release that are not statements of historical fact can be considered as forward-looking statements. Forward-looking statements are often identified by words such as “could”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend”, “should”, “May”, “are intended” to “,” are intended “or the negative of such terms and similar expressions. Statements containing forward-looking information, including, without limitation, with respect to the delivery of equipment and of products using the QuickStrip ™ product delivery method, recurring revenue generation, as of the date of this press release, plans, estimates, forecasts, projections, expectations or beliefs of RDT management as to future events or results and are believed to be reasonable based on information currently available to RDT management. Forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with x general economic conditions; adverse industry events; marketing costs; loss of markets; termination of WLM agreements; future legislative and regulatory developments regarding cannabis; inability to access sufficient capital from internal and external sources, and / or inability to access sufficient capital on favorable terms; the cannabis industry in Canada in general, income tax and regulatory matters; the ability to implement its business strategies; competetion; currency and interest rate fluctuations and other risks. Readers are cautioned that the foregoing list is not exhaustive. There can be no assurance that forward-looking information statements, although considered reasonable by RDT management at the time of preparation, will prove to be correct, as there can be no assurance that the plans, intentions or expectations on which they are based will be correct. will achieve. . Actual results and future events could differ materially from those anticipated in these forward-looking statements. Readers should not place undue reliance on forward-looking statements. The forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

See the source version on businesswire.com: https://www.businesswire.com/news/home/20211001005130/en/

Contacts

Investor contact:
Mark Upsdell, CEO
[email protected]
416-477-1052

Media contact:
Kim robinson
[email protected]
905-330-4055


Source link

Leave A Reply

Your email address will not be published.